£1.5 million investment to bring Bristol spin-out Halo Therapeutics first antiviral spray into clinic – – University of Bristol – All news

Clinical trials of an easy-to-use home therapeutic treatment for SARS-CoV-2 (coronaviruses) are underway following a £1.5 million investment into University of Bristol spin-out, Halo Therapeutics.University of Bristol – All news